AeRyon Kim, Ph.D. - Publications

2009 Johns Hopkins University, Baltimore, MD 
Immunology, Biochemistry, Pathology

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Song N, Sengupta S, Khoruzhenko S, Welsh RA, Kim A, Kumar MR, Sønder SU, Sidhom JW, Zhang H, Jie C, Siliciano RF, Sadegh-Nasseri S. Multiple genetic programs contribute to CD4 T cell memory differentiation and longevity by maintaining T cell quiescence. Cellular Immunology. 357: 104210. PMID 32987276 DOI: 10.1016/j.cellimm.2020.104210  0.72
2019 Kim A, Ishizuka IE, Hartman IZ, Poluektov Y, Narayan K, Sadegh-Nasseri S. Studying MHC Class II Peptide Loading and Editing In Vitro. Methods in Molecular Biology (Clifton, N.J.). 1988: 343-355. PMID 31147951 DOI: 10.1007/978-1-4939-9450-2_24  0.72
2018 Sadegh-Nasseri S, Kim A. Selection of immunodominant epitopes during antigen processing is hierarchical. Molecular Immunology. PMID 30146122 DOI: 10.1016/j.molimm.2018.08.011  0.72
2017 Kim A, Boronina TN, Cole RN, Darrah E, Sadegh-Nasseri S. Distorted Immunodominance by Linker Sequences or other Epitopes from a Second Protein Antigen During Antigen-Processing. Scientific Reports. 7: 46418. PMID 28422163 DOI: 10.1038/srep46418  0.72
2016 Darrah E, Kim A, Zhang X, Boronina T, Cole RN, Fava A, Giles JT, Bingham Iii CO, Chalmers MJ, Griffin PR, Sadegh-Nasseri S, Rosen A. Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis. Journal of Proteome Research. PMID 27700100 DOI: 10.1021/acs.jproteome.6b00617  0.72
2015 Sadegh-Nasseri S, Kim A. MHC Class II Auto-Antigen Presentation is Unconventional. Frontiers in Immunology. 6: 372. PMID 26257739 DOI: 10.3389/fimmu.2015.00372  0.72
2015 Sadegh-Nasseri S, Kim A. Exogenous antigens bind MHC class II first, and are processed by cathepsins later. Molecular Immunology. 68: 81-4. PMID 26254987 DOI: 10.1016/j.molimm.2015.07.018  0.72
2015 Kim A, Sadegh-Nasseri S. Determinants of immunodominance for CD4 T cells. Current Opinion in Immunology. 34: 9-15. PMID 25576665 DOI: 10.1016/j.coi.2014.12.005  0.72
2014 Kim A, Hartman IZ, Poore B, Boronina T, Cole RN, Song N, Ciudad MT, Caspi RR, Jaraquemada D, Sadegh-Nasseri S. Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources. Nature Communications. 5: 5369. PMID 25413013 DOI: 10.1038/ncomms6369  0.72
2013 Poluektov YO, Kim A, Sadegh-Nasseri S. HLA-DO and Its Role in MHC Class II Antigen Presentation. Frontiers in Immunology. 4: 260. PMID 24009612 DOI: 10.3389/fimmu.2013.00260  0.72
2013 Poluektov YO, Kim A, Hartman IZ, Sadegh-Nasseri S. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation. Plos One. 8: e71228. PMID 23951115 DOI: 10.1371/journal.pone.0071228  0.72
2013 Kim TH, Swierczewska M, Oh Y, Kim A, Jo DG, Park JH, Byun Y, Sadegh-Nasseri S, Pomper MG, Lee KC, Lee S. Mix to validate: a facile, reversible PEGylation for fast screening of potential therapeutic proteins in vivo. Angewandte Chemie (International Ed. in English). 52: 6880-4. PMID 23740787 DOI: 10.1002/anie.201302181  0.72
2013 Kim A, Ishizuka I, Hartman I, Poluektov Y, Narayan K, Sadegh-Nasseri S. Studying MHC class II peptide loading and editing in vitro. Methods in Molecular Biology (Clifton, N.J.). 960: 447-59. PMID 23329506 DOI: 10.1007/978-1-62703-218-6_33  0.72
2012 Sadegh-Nasseri S, Chou CL, Hartman IZ, Kim A, Narayan K. How HLA-DM works: recognition of MHC II conformational heterogeneity. Frontiers in Bioscience (Scholar Edition). 4: 1325-32. PMID 22652874  0.72
2010 Hartman IZ, Kim A, Cotter RJ, Walter K, Dalai SK, Boronina T, Griffith W, Lanar DE, Schwenk R, Krzych U, Cole RN, Sadegh-Nasseri S. A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes. Nature Medicine. 16: 1333-40. PMID 21037588 DOI: 10.1038/nm.2248  0.72
2010 Sadegh-Nasseri S, Natarajan S, Chou CL, Hartman IZ, Narayan K, Kim A. Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection. Immunologic Research. 47: 56-64. PMID 20066513 DOI: 10.1007/s12026-009-8138-1  0.72
2008 Chou CL, Mirshahidi S, Su KW, Kim A, Narayan K, Khoruzhenko S, Xu M, Sadegh-Nasseri S. Short peptide sequences mimic HLA-DM functions. Molecular Immunology. 45: 1935-43. PMID 18054387 DOI: 10.1016/j.molimm.2007.10.033  0.72
2007 Narayan K, Chou CL, Kim A, Hartman IZ, Dalai S, Khoruzhenko S, Sadegh-Nasseri S. HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes. Nature Immunology. 8: 92-100. PMID 17143275 DOI: 10.1038/ni1414  0.72
Show low-probability matches.